Instil Net Income vs Cost Of Revenue Analysis

TIL Stock

USD 24.76 1.40 5.99%

Instil Bio financial indicator trend analysis is infinitely more than just investigating Instil Bio recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Instil Bio is a good investment. Please check the relationship between Instil Bio Net Income and its Cost Of Revenue accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Instil Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Instil Stock please use our How to buy in Instil Stock guide.

Net Income vs Cost Of Revenue

Net Income vs Cost Of Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Instil Bio Net Income account and Cost Of Revenue. At this time, the significance of the direction appears to have pay attention.

The correlation between Instil Bio's Net Income and Cost Of Revenue is -0.95. Overlapping area represents the amount of variation of Net Income that can explain the historical movement of Cost Of Revenue in the same time period over historical financial statements of Instil Bio, assuming nothing else is changed. The correlation between historical values of Instil Bio's Net Income and Cost Of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income of Instil Bio are associated (or correlated) with its Cost Of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost Of Revenue has no effect on the direction of Net Income i.e., Instil Bio's Net Income and Cost Of Revenue go up and down completely randomly.

Correlation Coefficient

-0.95

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Instil Bio financial statement analysis. It represents the amount of money remaining after all of Instil Bio operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Cost Of Revenue

Cost of Revenue is found on Instil Bio income statement and represents the costs associated with goods and services Instil Bio provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most indicators from Instil Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Instil Bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Instil Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Instil Stock please use our How to buy in Instil Stock guide.The value of Tax Provision is estimated to slide to about (635.2 K). The value of Selling General Administrative is expected to slide to about 38.5 M

	2021	2022	2023	2024 (projected)
Interest Income	80K	3.7M	8.5M	8.9M
Net Interest Income	3.8M	1.8M	4.5M	4.7M

Interest Income Net Interest Income

Instil Bio fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets	Net Working Capital	Property Plant Equipment	Other Liab	Non Currrent Assets Other	Other Assets	Net Receivables
Total Assets		0.91	0.93	0.9	0.85	0.91	-0.01	-0.74	0.85	0.37	0.93	0.98	0.42	0.43	0.91	0.78	0.54	0.91	0.9	0.98	0.98	0.92	0.4	0.58	0.6	0.85
Other Current Liab	0.91		1.0	0.92	0.7	0.82	-0.03	-0.51	0.86	0.25	0.82	0.92	0.13	0.2	0.87	0.75	0.33	0.9	0.81	0.92	0.91	0.73	0.08	0.82	0.74	0.77
Total Current Liabilities	0.93	1.0		0.92	0.71	0.83	-0.05	-0.52	0.88	0.29	0.83	0.93	0.15	0.24	0.88	0.74	0.37	0.9	0.81	0.93	0.92	0.75	0.1	0.8	0.73	0.77
Total Stockholder Equity	0.9	0.92	0.92		0.88	0.85	0.3	-0.7	0.75	-0.04	0.86	0.88	0.36	0.0	0.97	0.91	0.13	0.99	0.84	0.88	0.87	0.84	0.36	0.72	0.73	0.89
Net Tangible Assets	0.85	0.7	0.71	0.88		0.91	0.5	-0.95	0.5	-0.09	0.92	0.76	0.63	0.1	0.88	0.94	0.2	0.92	0.91	0.76	0.76	0.96	0.72	0.31	0.39	0.95
Property Plant And Equipment Net	0.91	0.82	0.83	0.85	0.91		0.25	-0.88	0.57	0.19	1.0	0.81	0.43	0.34	0.81	0.88	0.44	0.9	1.0	0.82	0.81	0.94	0.53	0.35	0.31	0.93
Net Debt	-0.01	-0.03	-0.05	0.3	0.5	0.25		-0.5	-0.38	-0.87	0.21	-0.13	0.41	-0.68	0.22	0.57	-0.65	0.35	0.26	-0.13	-0.14	0.26	0.5	-0.16	-0.1	0.41
Retained Earnings	-0.74	-0.51	-0.52	-0.7	-0.95	-0.88	-0.5		-0.3	0.03	-0.89	-0.61	-0.68	-0.23	-0.7	-0.84	-0.3	-0.77	-0.88	-0.62	-0.62	-0.94	-0.85	-0.01	-0.1	-0.89
Accounts Payable	0.85	0.86	0.88	0.75	0.5	0.57	-0.38	-0.3		0.52	0.61	0.94	0.17	0.42	0.79	0.44	0.52	0.69	0.56	0.93	0.93	0.62	0.01	0.8	0.83	0.53
Cash	0.37	0.25	0.29	-0.04	-0.09	0.19	-0.87	0.03	0.52		0.23	0.42	-0.09	0.94	0.04	-0.24	0.94	-0.04	0.18	0.42	0.44	0.18	-0.12	0.08	0.04	-0.03
Non Current Assets Total	0.93	0.82	0.83	0.86	0.92	1.0	0.21	-0.89	0.61	0.23		0.84	0.44	0.37	0.84	0.87	0.47	0.9	0.99	0.85	0.84	0.96	0.56	0.37	0.35	0.94
Cash And Short Term Investments	0.98	0.92	0.93	0.88	0.76	0.81	-0.13	-0.61	0.94	0.42	0.84		0.38	0.43	0.9	0.67	0.55	0.86	0.8	1.0	1.0	0.85	0.29	0.67	0.7	0.76
Common Stock Shares Outstanding	0.42	0.13	0.15	0.36	0.63	0.43	0.41	-0.68	0.17	-0.09	0.44	0.38		0.14	0.37	0.37	0.17	0.38	0.43	0.39	0.39	0.62	0.61	-0.19	-0.03	0.37
Non Current Liabilities Total	0.43	0.2	0.24	0.0	0.1	0.34	-0.68	-0.23	0.42	0.94	0.37	0.43	0.14		0.08	-0.11	0.99	0.03	0.33	0.43	0.45	0.36	0.17	-0.12	-0.12	0.12
Other Current Assets	0.91	0.87	0.88	0.97	0.88	0.81	0.22	-0.7	0.79	0.04	0.84	0.9	0.37	0.08		0.87	0.21	0.96	0.8	0.9	0.9	0.87	0.46	0.69	0.77	0.9
Other Stockholder Equity	0.78	0.75	0.74	0.91	0.94	0.88	0.57	-0.84	0.44	-0.24	0.87	0.67	0.37	-0.11	0.87		0.01	0.95	0.88	0.68	0.67	0.85	0.59	0.44	0.46	0.97
Total Liab	0.54	0.33	0.37	0.13	0.2	0.44	-0.65	-0.3	0.52	0.94	0.47	0.55	0.17	0.99	0.21	0.01		0.15	0.44	0.55	0.56	0.46	0.19	-0.01	-0.02	0.22
Net Invested Capital	0.91	0.9	0.9	0.99	0.92	0.9	0.35	-0.77	0.69	-0.04	0.9	0.86	0.38	0.03	0.96	0.95	0.15		0.89	0.86	0.85	0.88	0.43	0.64	0.65	0.94
Property Plant And Equipment Gross	0.9	0.81	0.81	0.84	0.91	1.0	0.26	-0.88	0.56	0.18	0.99	0.8	0.43	0.33	0.8	0.88	0.44	0.89		0.81	0.8	0.94	0.54	0.34	0.3	0.93
Total Current Assets	0.98	0.92	0.93	0.88	0.76	0.82	-0.13	-0.62	0.93	0.42	0.85	1.0	0.39	0.43	0.9	0.68	0.55	0.86	0.81		1.0	0.86	0.3	0.67	0.7	0.76
Net Working Capital	0.98	0.91	0.92	0.87	0.76	0.81	-0.14	-0.62	0.93	0.44	0.84	1.0	0.39	0.45	0.9	0.67	0.56	0.85	0.8	1.0		0.85	0.3	0.66	0.7	0.76
Property Plant Equipment	0.92	0.73	0.75	0.84	0.96	0.94	0.26	-0.94	0.62	0.18	0.96	0.85	0.62	0.36	0.87	0.85	0.46	0.88	0.94	0.86	0.85		0.7	0.3	0.38	0.92
Other Liab	0.4	0.08	0.1	0.36	0.72	0.53	0.5	-0.85	0.01	-0.12	0.56	0.29	0.61	0.17	0.46	0.59	0.19	0.43	0.54	0.3	0.3	0.7		-0.3	-0.08	0.66
Non Currrent Assets Other	0.58	0.82	0.8	0.72	0.31	0.35	-0.16	-0.01	0.8	0.08	0.37	0.67	-0.19	-0.12	0.69	0.44	-0.01	0.64	0.34	0.67	0.66	0.3	-0.3		0.94	0.4
Other Assets	0.6	0.74	0.73	0.73	0.39	0.31	-0.1	-0.1	0.83	0.04	0.35	0.7	-0.03	-0.12	0.77	0.46	-0.02	0.65	0.3	0.7	0.7	0.38	-0.08	0.94		0.45
Net Receivables	0.85	0.77	0.77	0.89	0.95	0.93	0.41	-0.89	0.53	-0.03	0.94	0.76	0.37	0.12	0.9	0.97	0.22	0.94	0.93	0.76	0.76	0.92	0.66	0.4	0.45

Click cells to compare fundamentals

Instil Bio Account Relationship Matchups

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Instil Bio is a strong investment it is important to analyze Instil Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Instil Bio's future performance. For an informed investment choice regarding Instil Stock, refer to the following important reports:

How To Invest In Instil

Details

Is Instil Stock a good investment?

Details

What is Instil Bio's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Instil Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Instil Stock please use our How to buy in Instil Stock guide.

You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Instil Bio. If investors know Instil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Instil Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(11.56)

Return On Assets

(0.12)

Return On Equity

(0.49)

The market value of Instil Bio is measured differently than its book value, which is the value of Instil that is recorded on the company's balance sheet. Investors also form their own opinion of Instil Bio's value that differs from its market value or its book value, called intrinsic value, which is Instil Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Instil Bio's market value can be influenced by many factors that don't directly affect Instil Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Instil Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Instil Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Instil Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Instil Net Income vs Cost Of Revenue Analysis

Net Income vs Cost Of Revenue

Net Income vs Cost Of Revenue Correlation Analysis

Correlation Coefficient

Net Income

Cost Of Revenue

Instil Bio fundamental ratios Correlations

Instil Bio Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Liabilities	+ 1.0	Other Current Liab
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Total Current Assets	+ 1.0	Cash And Short Term Investments
Net Working Capital	+ 1.0	Cash And Short Term Investments
Net Working Capital	+ 1.0	Total Current Assets

Retained Earnings	- 0.95	Net Tangible Assets
Property Plant Equipment	- 0.94	Retained Earnings
Net Receivables	- 0.89	Retained Earnings
Non Current Assets Total	- 0.89	Retained Earnings
Property Plant And Equipment Gross	- 0.88	Retained Earnings
Retained Earnings	- 0.88	Property Plant And Equipment Net